SCHEMBL18132580

SCHEMBL18132580

O=C(O)c1ccccc1C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.73
▸ CA12 O43570 1/20 0.60
▸ CA9 Q16790 1/20 0.60
▸ KDM4E B2RXH2 7/20 0.60
▸ ALDH1A1 P00352 5/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ KLK7 P49862 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ CYP1A2 P05177 2/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ XDH P47989 1/20 0.56
▸ KMT2A Q03164 7/20 0.54
▸ MEN1 O00255 6/20 0.54
▸ LMNA P02545 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ POLB P06746 1/20 0.54
▸ HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20777365 0.85 MAPT (0.68) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL22173221 0.85 MAPT (0.68) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL20772671 0.84 MAPT (0.69) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL20777435 0.82 MAPT (0.64) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL30832831 0.82 MAPT (0.64) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL20772536 0.80 MAPT (0.65) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL1737847 0.80 MAPT (0.64) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL30081451 0.80 MAPT (0.64) MAPTKDM4EALDH1A1RAB9AKLK7
SCHEMBL20777328 0.79 MAPT (0.75) MAPTCA12CA9KDM4EALDH1A1
SCHEMBL30832878 0.78 MAPT (0.62) MAPTKDM4EALDH1A1RAB9AKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10166237-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2019-01-01 — — US disclosed
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2017-04-27 — — US disclosed
US-9464065-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2016-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10166237-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, BMP2 MAPT 4575/4885CA12 416/4885CA9 926/4885
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, BMP2 MAPT 4575/4885CA12 416/4885CA9 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback